HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daisuke Watanabe Selected Research

Hyperglycemia

1/2022Compound heterozygous variants of the NARS2 gene in siblings with developmental delay, epilepsy, and neonatal diabetes syndrome.
11/2021iGlarLixi reduces residual hyperglycemia in Japanese patients with type 2 diabetes uncontrolled on basal insulin: A post-hoc analysis of the LixiLan JP-L trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daisuke Watanabe Research Topics

Disease

25Neoplasms (Cancer)
01/2023 - 01/2004
14Infections
02/2024 - 06/2006
11Hyperaldosteronism (Conn Syndrome)
12/2023 - 08/2004
10Diabetic Retinopathy (Retinopathy, Diabetic)
04/2009 - 09/2004
9Herpes Zoster
02/2024 - 05/2015
9Type 2 Diabetes Mellitus (MODY)
01/2023 - 03/2014
7Melanoma (Melanoma, Malignant)
01/2020 - 06/2008
7Retinal Neovascularization
08/2007 - 05/2002
6Pain (Aches)
12/2023 - 01/2016
6Adenoma (Adenomas)
12/2023 - 12/2014
6Hypertension (High Blood Pressure)
12/2020 - 08/2004
6Ischemia
09/2007 - 05/2002
5COVID-19
04/2025 - 01/2021
5Inflammation (Inflammations)
01/2024 - 01/2017
5Cushing Syndrome
09/2023 - 12/2014
5Hyperhidrosis
09/2023 - 06/2008
5Heart Failure
01/2023 - 08/2004
5Prostatic Neoplasms (Prostate Cancer)
12/2022 - 12/2020
4Osteoporosis
12/2022 - 01/2015
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2019 - 01/2016
4Skin Neoplasms (Skin Cancer)
01/2011 - 04/2007
3Ulcerative Colitis
02/2024 - 12/2018
3Disease Progression
12/2021 - 03/2014
3Ulcer
08/2021 - 11/2006
3Edema (Dropsy)
01/2019 - 01/2009
3Essential Hypertension
01/2017 - 07/2014
3Retinal Vein Occlusion
04/2009 - 08/2006
3Necrosis
06/2008 - 12/2005
3Acute Liver Failure (Fulminant Hepatic Failure)
01/2006 - 03/2005
2Exanthema (Rash)
02/2024 - 11/2017
2Adenocarcinoma
05/2023 - 11/2015
2Abdominal Obesity
01/2023 - 10/2017
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2023 - 01/2017
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
10/2022 - 01/2018
2Arteriosclerosis
10/2022 - 01/2017
2Proteinuria
08/2022 - 05/2018
2Hyperglycemia
01/2022 - 11/2021
2Autoimmune Diseases (Autoimmune Disease)
12/2021 - 01/2018
2Stroke (Strokes)
12/2021 - 01/2021
2Lymphoproliferative Disorders (Lymphoproliferative Disorder)
08/2021 - 05/2007

Drug/Important Bio-Agent (IBA)

8Glucose (Dextrose)FDA LinkGeneric
10/2022 - 11/2013
8AcidsIBA
06/2012 - 02/2005
8Retinaldehyde (Retinal)IBA
11/2007 - 05/2002
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2007 - 05/2004
7AldosteroneIBA
12/2023 - 08/2004
7VaccinesIBA
10/2023 - 01/2007
7Insulin (Novolin)FDA Link
01/2022 - 01/2010
71-phenyl-3,3-dimethyltriazene (PDT)IBA
06/2012 - 02/2005
6Prorenin ReceptorIBA
01/2020 - 06/2013
6SteroidsIBA
09/2019 - 08/2004
5Hydrocortisone (Cortisol)FDA LinkGeneric
09/2023 - 12/2014
5Hypoglycemic Agents (Hypoglycemics)IBA
10/2022 - 04/2014
5lixisenatideIBA
12/2021 - 01/2017
5CytokinesIBA
01/2021 - 01/2017
5Infliximab (Remicade)FDA Link
12/2018 - 01/2010
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2018 - 12/2005
4DNA (Deoxyribonucleic Acid)IBA
02/2024 - 09/2007
4Type A Botulinum Toxins (Botox)FDA Link
09/2023 - 06/2008
4Biomarkers (Surrogate Marker)IBA
12/2022 - 03/2012
4Proteins (Proteins, Gene)FDA Link
04/2022 - 05/2003
4Insulin Glargine (Lantus)FDA Link
12/2021 - 01/2017
4LipidsIBA
01/2020 - 12/2012
3Anti-Bacterial Agents (Antibiotics)IBA
04/2023 - 09/2004
3ASP2151IBA
03/2023 - 11/2017
3AndrogensIBA
11/2021 - 12/2020
3Blood Glucose (Blood Sugar)IBA
11/2021 - 12/2012
3apremilastIBA
05/2021 - 12/2019
3AntibodiesIBA
05/2019 - 07/2011
3Adrenocorticotropic Hormone (ACTH)FDA Link
01/2019 - 12/2014
3Herpes Zoster VaccineIBA
01/2019 - 01/2018
3Subunit VaccinesIBA
01/2018 - 05/2015
3Messenger RNA (mRNA)IBA
09/2009 - 05/2002
3Tissue Plasminogen Activator (Alteplase)FDA Link
04/2009 - 08/2006
3ErythropoietinFDA Link
11/2007 - 08/2005
3Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
11/2007 - 08/2005
2Adrenal Cortex Hormones (Corticosteroids)IBA
05/2024 - 10/2023
2tofacitinibIBA
02/2024 - 06/2019
2Valacyclovir (Valtrex)FDA LinkGeneric
02/2024 - 11/2017
2IronIBA
01/2024 - 12/2022
2C-Reactive ProteinIBA
11/2023 - 12/2019
2COVID-19 VaccinesIBA
10/2023 - 01/2023
2Amlodipine (Norvasc)FDA LinkGeneric
01/2023 - 06/2018
2aliskirenFDA Link
01/2023 - 06/2018
2Androgen Receptors (Androgen Receptor)IBA
07/2022 - 11/2021
2Therapeutic UsesIBA
04/2022 - 01/2018
2Hormones (Hormone)IBA
11/2021 - 08/2004
2ruxolitinibIBA
10/2021 - 02/2020

Therapy/Procedure

25Therapeutics
05/2024 - 09/2004
10Photochemotherapy (Photodynamic Therapy)
06/2012 - 02/2005
6Drug Therapy (Chemotherapy)
11/2022 - 01/2016
4Aftercare (After-Treatment)
09/2023 - 10/2015
4Glycemic Control
10/2022 - 03/2014
4Hematopoietic Stem Cell Transplantation
12/2021 - 01/2016
3Castration
11/2021 - 12/2020
3Myotomy
12/2019 - 10/2018
3Adrenalectomy
05/2018 - 12/2014
3Vitrectomy
01/2009 - 06/2005
2Coronary Artery Bypass (Coronary Artery Bypass Surgery)
03/2024 - 01/2015
2Activities of Daily Living (ADL)
01/2023 - 09/2022
2Thrombectomy
12/2021 - 01/2021